OVENTUS LAUNCHES $12M ASX TILT

Written on the 17 June 2016

OVENTUS LAUNCHES $12M ASX TILT

A BRISBANE-based sleep disorder device manufacturer and developer has launched an IPO to raise $12 million.

Oventus is offering 24 million shares to be listed on the ASX at 50 cents apiece, led and underwritten by Bell Potter Securities.

The company's O2VENT treats sleep apnoea and snoring by creating an airway to bypass nasal, soft palate and tongue obstructions.

The US Food and Drug Administration has approved the appliance for marketing, paving the way for international expansion.

Funds raised under the offer will be used to continue the commercialisation and distribution of the O2VENT in Australia, develop additional devices and expand to new markets.

Oventus chairman Mel Bridges says the company plans to become a global leader in the treatment of obstructive sleep apnoea.

The condition involves repeated episodes of airway obstruction during sleep and also has a direct link to more serious health issues.

"We are pleased to invite investors to join with Oventus as we embark on an exciting development program and help address a significant health and lifestyle issue for millions of people around the world," Bridges says.

Oventus estimates that the current global sleep apnoea market for therapeutic devices is worth US$3.5 billion and growing by 7.4 per cent each year.

The company lodged its prospectus with the ASX on June 8.

 


Latest News

STAFF CHURN BLAMED FOR MCGRATH EARNINGS DOWNGRADE

MCGRATH will fail to meet earnings forecasts after some of its star real estate agents defected to growing Perth firm...

MCBAIN RESIGNS AS BELLAMY'S DIRECTOR WHILE THIRD CLASS ACTION MOVES CLOSER TO SECURING FUNDING

LAURA McBain (pictured) has resigned as a director of Bellamy's Organic (ASX: BAL) today, effective immediatel...

REDBUBBLE TO MISS IPO FORECASTS

REDBUBBLE, the online marketplace for independent artists, will miss a series of forecasts set out in its IPO in its ...

BLUESCOPE CONTINUES STRONG RUN WITH GUIDANCE UPGRADE

BLUESCOPE Steel (ASX: BSL) is trading up 7.51 per cent at $11.16 per share after upgrading its half-year guidance thi...

Related News

CARSALES CEO RETIRES AS NEW COMPETITOR COX FINALISES MERGER

CARSALES will have a new CEO as it takes on a fresh challenger to its crown as the dominant online car sales portal i...

BUSINESS CONFIDENCE AT A SIX-YEAR HIGH

SMALL and medium businesses have entered 2017 with their confidence at a six-year high, building on strong gains m...

CONSUMERS PESSIMISTIC ENTERING 2017

CONSUMER confidence remains at its weakest point since April 2016, according to the latest Westpac Melbourne Institut...

RISE OF STARTUP SUPPORT PROGRAMS NOT AS ROSY AT IT SEEMS

ENTREPRENEURIAL cultivation companies in Australia are appearing quickly, but questions have been raised about whe...

Contact us

Email News Update Sign Up Contact Details
Subscriptions

PO Box 2087
Brisbane QLD 4001

LoginTell a FriendSign Up to Newsletter